Very low birth weight infant care: adherence to a new nutrition protocol improves growth outcomes and reduces

Beatrice M Stefanescu1, Maria Gillam-Krakauer1, Andrei R Stefanescu2

  • 1Department of Pediatrics, Division of Neonatology, University of New Mexico School of Medicine, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.

Early Human Development
|February 20, 2016
PubMed

Insights

A nutrition bundle improved growth in very low birth weight (VLBW) infants, reducing complications. This standardized approach enhanced linear and head circumference growth, decreasing postnatal growth restriction.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Clinical Pathways

Background:

  • Very low birth weight (VLBW) infants face significant risks of postnatal growth restriction due to challenges in nutrient delivery and illness.
  • Variability in clinical practices can negatively impact growth outcomes in VLBW infants.
  • Integrated clinical pathways offer a structured approach to improve growth and reduce complications.

Purpose of the Study:

  • To evaluate the impact of a comprehensive nutrition bundle on anthropometric parameters in VLBW infants at 36 weeks postmenstrual age (PMA).
  • To assess secondary outcomes including time to enteral feeding, central line duration, and incidence of necrotizing enterocolitis (NEC) and sepsis/sepsis-like episodes.

Main Methods:

  • Implementation of a nutrition bundle with standardized enteral feeding protocols and central line management in July 2012.
  • Study included VLBW infants (<1500 g, <34 weeks gestation) over a 1-year pre- and post-intervention period.
  • Comparison of anthropometric z scores, feeding milestones, central line days, and clinical outcomes between the intervention (Nutrition bundle) and control (Conventional) groups.

Main Results:

  • The Nutrition bundle group showed significantly higher median delta z scores for length and head circumference at 36 weeks PMA compared to the Conventional group.
  • Fewer infants in the Nutrition bundle group experienced severe growth restriction.
  • The intervention group demonstrated significantly shorter times to first and full enteral feedings, reduced central line-days, and decreased incidence of NEC and sepsis/sepsis-like episodes.

Conclusions:

  • A comprehensive nutrition bundle effectively improved linear and head circumference growth in VLBW infants.
  • The standardized approach led to a reduction in postnatal growth restriction and associated comorbidities.
  • Implementation of integrated clinical pathways for nutrition management is beneficial for VLBW infant outcomes.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
2.3K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
15
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Microbial Nutrition01:28

Microbial Nutrition

Organisms exhibit remarkable metabolic diversity, categorized based on how they acquire energy and carbon. These strategies enable survival in various ecological niches and are essential for maintaining energy flow and nutrient cycling within ecosystems.Energy and Carbon SourcesOrganisms are classified as phototrophs or chemotrophs based on energy acquisition. Phototrophs use light as their energy source, while chemotrophs rely on oxidizing chemical compounds. Further differentiation arises...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369